First Pacific Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-2,500
Closed -$409K 140
2017
Q4
$409K Sell
2,500
-7,000
-74% -$1.26M ﹤0.01% 133
2017
Q3
$1.95M Sell
9,500
-200
-2% -$46.5K 0.02% 89
2017
Q2
$2.36M Sell
9,700
-700
-7% -$164K 0.02% 86
2017
Q1
$2.48M Sell
10,400
-6,100
-37% -$1.42M 0.02% 79
2016
Q4
$3.46M Buy
+16,500
New +$3.42M 0.03% 83
2016
Q1
Sell
-24,100
Closed -$7.53M 115
2015
Q4
$7.53M Sell
24,100
-6,480
-21% -$1.93M 0.07% 67
2015
Q3
$8.31M Buy
+30,580
New +$9.39M 0.07% 92

Other funds holding AGN

First Pacific Advisors's AGN Position: Q1 2018 in Review

First Pacific Advisors sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 2,500 shares — an estimated $409K sold.

First Pacific Advisors first reported a position in AGN in Q3 2015 and held it in 7 quarters. The position peaked at $8.31M in Q3 2015. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • First Pacific Advisors reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • First Pacific Advisors sold 2,500 Allergan plc shares in Q1 2018, an estimated $409K.
  • First Pacific Advisors first reported a position in Allergan plc in Q3 2015 and held it in 7 quarters.
  • First Pacific Advisors's Allergan plc position peaked at $8.31M in Q3 2015.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on First Pacific Advisors's 13F filing for Q1 2018, filed 14 May 2018.